InvestorsHub Logo
Followers 32
Posts 1683
Boards Moderated 0
Alias Born 01/11/2014

Re: None

Saturday, 09/16/2017 7:13:13 AM

Saturday, September 16, 2017 7:13:13 AM

Post# of 2099
Good news for the VB111 combination for rGBM patients. This would make the combination more affordable (considering that VBLT is planning to price its drug at $150K per annum)


http://www.onclive.com/web-exclusives/fda-approves-first-biosimilar-for-cancer-treatment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News